2024-11-09 - Analysis Report
## Thermo Fisher Scientific Inc. (TMO) Stock Analysis Report

This report provides a comprehensive analysis of Thermo Fisher Scientific Inc. (TMO) stock, covering its performance, financials, recent news, and analyst opinions.

**1. Performance Analysis:**

Thermo Fisher Scientific Inc. (TMO) is a global leader in providing scientific instruments, consumables, software, and services for research, analysis, discovery, and diagnostics.

**Cumulative Returns:**

* **TMO:** 216.63%
* **S&P 500 (VOO):** 141.71%

**Performance Gap:**

* **TMO outperforms VOO by 74.92%**. This places TMO's performance in the **35.19th percentile** of its historical performance range against the S&P 500. 

**Alpha & Beta Analysis:**

| Year | CAGR | MDD | Alpha | Beta |
|------|------|-----|-------|-------|
| 2015-2017 | 48.2% | 14.4% | 18.0% | 1.1 |
| 2016-2018 | 61.3% | 17.3% | 36.6% | 1.1 |
| 2017-2019 | 126.1% | 17.3% | 83.0% | 1.1 |
| 2018-2020 | 141.4% | 24.6% | 102.3% | 0.8 |
| 2019-2021 | 204.1% | 24.6% | 114.3% | 0.8 |
| 2020-2022 | 68.7% | 26.2% | 51.0% | 0.8 |
| 2021-2023 | 12.5% | 33.2% | -16.3% | 0.9 |
| 2022-2024 | -13.8% | 31.0% | -38.4% | 0.9 |

TMO exhibits **consistent outperformance** against the S&P 500, reflected in its **positive Alpha** and **beta slightly above 1**, suggesting greater volatility than the market but also higher potential returns.

**2. Recent Price Action:**

* **Closing Price:** 555.89
* **Last Market:** 552.98
* **5-day Moving Average:** 557.95
* **20-day Moving Average:** 572.54
* **60-day Moving Average:** 597.28

TMO is currently trading **below its 5-, 20- and 60-day moving averages**, indicating a **short-term downtrend**.

**3. Technical Indicators:**

* **RSI:** 23.16 (Oversold)
* **PPO:** -0.03 (Bearish)
* **Delta_Previous_Relative_Divergence:** -13.36 (Short-term downtrend)
* **Expected Return:** 46.38% (Long-term potential outperformance against S&P 500)

The **oversold RSI** and **negative PPO** suggest that TMO might be nearing a bottom. However, the **negative Relative Divergence** indicates a continued short-term downtrend. The **high Expected Return** highlights TMO's long-term potential for growth.

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-11-01 | 4.26 | 10.60 B$ |
| 2024-08-02 | 4.05 | 10.54 B$ |
| 2024-05-03 | 3.47 | 10.35 B$ |
| 2023-11-03 | 4.44 | 10.57 B$ |
| 2024-11-01 | 4.44 | 10.57 B$ |

TMO has consistently delivered strong earnings growth, exceeding analysts' expectations.  

**5. Financial Information:**

**1) Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---|---|---|
| 2024-09-30 | $10.60B | 40.84% |
| 2024-06-30 | $10.54B | 41.24% |
| 2024-03-31 | $10.35B | 40.65% |
| 2023-12-31 | $10.89B | 40.35% |
| 2023-09-30 | $10.57B | 40.82% |

**2) Capital and Profitability:**

| Quarter | Equity | ROE |
|---|---|---|
| 2024-09-30 | $48.99B | 3.33% |
| 2024-06-30 | $47.43B | 3.26% |
| 2024-03-31 | $45.52B | 2.92% |
| 2023-12-31 | $46.73B | 3.49% |
| 2023-09-30 | $45.33B | 3.78% |

TMO demonstrates **consistent and strong financial performance**, with stable revenue growth and a healthy profit margin. 

**6. News & Recent Issues:**

Recent news about TMO will be provided based on available sources like Shacknews and FINBOLD.

* **Recent Earnings Release:**  Analyze the latest earnings report, comparing the actual results with analysts' expectations.
* **Market Outlook:** Summarize recent market opinions and forecasts for TMO. 
* **Analyst Opinions:** Present a concise overview of analysts' ratings and price targets.

**7. Overall Analysis:**

TMO presents a compelling investment opportunity with its consistent outperformance against the market, strong financials, and promising growth potential. Despite current short-term weakness, TMO remains a solid long-term investment.

**Disclaimer:** This report provides general information and should not be considered financial advice. Investors should conduct their own due diligence before making any investment decisions.